|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||||
| CURRENT ASSETS: | |||||||||||||||
| Cash | |||||||||||||||
| Accounts receivable | |||||||||||||||
| Note receivable, net | |||||||||||||||
| Interest receivable | |||||||||||||||
| Due from related parties | |||||||||||||||
| Assets from discontinued operations | |||||||||||||||
| Total Current assets | |||||||||||||||
| TOTAL ASSETS | |||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ DEFICIT | |||||||||||||||
| CURRENT LIABILITIES: | |||||||||||||||
| Accounts payable and accrued liabilities | |||||||||||||||
| Accrued compensation | |||||||||||||||
| Due to a related party | |||||||||||||||
| Related Party | |||||||||||||||
| Total due to a related party | |||||||||||||||
| Non convertible promissory notes | |||||||||||||||
| Related Party | |||||||||||||||
| Nonrelated Party | |||||||||||||||
| Total non convertible promissory notes | |||||||||||||||
| Accrued interest | |||||||||||||||
| Notes payable | |||||||||||||||
| Related Party | |||||||||||||||
| Total notes payable | |||||||||||||||
| Accrued interest | |||||||||||||||
| Related Party | |||||||||||||||
| Nonrelated Party | |||||||||||||||
| Total accrued interest | |||||||||||||||
| Settlement liability | |||||||||||||||
| Related Party | |||||||||||||||
| Nonrelated Party | |||||||||||||||
| Total settlement liability | |||||||||||||||
| Settlement liability - related party | |||||||||||||||
| Derivative liabilities | |||||||||||||||
| Stock payable | |||||||||||||||
| Liabilities from discontinued operations | |||||||||||||||
| Total Current Liabilities | |||||||||||||||
| TOTAL LIABILITIES | |||||||||||||||
| STOCKHOLDERS’ DEFICIT: | |||||||||||||||
| Series A Preferred stock, 200,000 shares authorized, $0.001 par value; 100,000 and 100,000 issued and outstanding, respectively | |||||||||||||||
| Common stock, 2,499,900,000 shares authorized, $0.001 par value; 66,377,720 and 63,994,148 issued and outstanding, respectively | |||||||||||||||
| Stock payable | |||||||||||||||
| Additional paid-in capital | |||||||||||||||
| Accumulated deficit | |||||||||||||||
| Total Stockholders’ equity (deficit) | |||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIT) |
Loading...
